ZA981391B - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- ZA981391B ZA981391B ZA981391A ZA981391A ZA981391B ZA 981391 B ZA981391 B ZA 981391B ZA 981391 A ZA981391 A ZA 981391A ZA 981391 A ZA981391 A ZA 981391A ZA 981391 B ZA981391 B ZA 981391B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3617297 | 1997-02-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA981391B true ZA981391B (en) | 1998-08-24 |
Family
ID=12462338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA981391A ZA981391B (en) | 1997-02-20 | 1998-02-19 | Pharmaceutical composition |
Country Status (1)
Country | Link |
---|---|
ZA (1) | ZA981391B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2798467C1 (en) * | 2023-03-28 | 2023-06-23 | Федеральное государственное автономное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" | 2a-alkoxycarbonyl-5-phenyl-1h-spiro[cyclopropa[2,3]pyrrolo[1,2-a]quinoxaline-3,3'-indoline]-1,2,2',4(2ah,5h)-tetraons |
-
1998
- 1998-02-19 ZA ZA981391A patent/ZA981391B/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2798467C1 (en) * | 2023-03-28 | 2023-06-23 | Федеральное государственное автономное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" | 2a-alkoxycarbonyl-5-phenyl-1h-spiro[cyclopropa[2,3]pyrrolo[1,2-a]quinoxaline-3,3'-indoline]-1,2,2',4(2ah,5h)-tetraons |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9706089D0 (en) | Pharmaceutical composition | |
GB9727053D0 (en) | Pharmaceutical compositions | |
CY2569B1 (en) | Pharmaceutical compositions | |
EP0978288A4 (en) | Medicinal composition | |
GB9818591D0 (en) | Pharmaceutical composition | |
IL133928A0 (en) | Pharmaceutical composition containing peptichemio | |
GB9717444D0 (en) | Pharmaceutical composition | |
HUP0002455A3 (en) | Gastric-retained pharmaceutical composition | |
GB9717428D0 (en) | Pharmaceutical composition | |
GB9723985D0 (en) | Pharmaceutical compositions | |
HUP0004669A3 (en) | Pharmaceutical compositions | |
IL122920A (en) | Castrointestinal drug composition | |
EP1124557A4 (en) | Pharmaceutical composition | |
HU9700632D0 (en) | Pharmaceutical compositions | |
GB9623962D0 (en) | Pharmaceutical composition | |
GB9717770D0 (en) | Pharmaceutical composition | |
GB2321190B (en) | Pharmaceutical composition | |
GB9921495D0 (en) | Pharmaceutical compositions | |
GB9726781D0 (en) | Pharmaceutical composition | |
GB9712097D0 (en) | Pharmaceutical composition | |
GB9717575D0 (en) | Pharmaceutical composition | |
GB9710632D0 (en) | Pharmaceutical composition | |
GB9702517D0 (en) | Pharmaceutical composition | |
GB9710525D0 (en) | Pharmaceutical composition | |
HU9701598D0 (en) | Pharmaceutical composition |